Liver disease does not discriminate. And yet…

Hepatitis C (HCV) is more prevalent in African Americans than in any other racial group in the U.S. and African Americans are more likely to be deemed ineligible for HCV treatment than non-African Americans.¹
African and Hispanic Americans are the two groups of people who have the largest increase in incidence of liver cancer and the lowest rates of curative treatment.²
African and Hispanic Americans are more likely to be uninsured than white Americans.^{3, 4}

This is not acceptable.

We at the American Liver Foundation (ALF) are devastated by recent events and stand firmly against racism and inequality in all forms. We pledge to expand our offerings in marginalized communities, and to continue to treat everyone with the dignity, kindness and compassion that is their birthright.

ALF’s vision is a world without liver disease. Until that day comes, we will continue to fight for equal access to health care and better outcomes for all people impacted by liver disease.

Last updated on September 15th, 2023 at 11:00 am

Diversity Policy